Cyclin D1 G870A Polymorphism and Risk of Nasopharyngeal Carcinoma: A Meta-Analysis

被引:5
作者
Li, Meng [1 ,2 ]
Dai, Weijian [3 ]
Zhou, Huanqin [1 ,2 ]
机构
[1] Zhejiang Hosp, Dept Lab Med, Hangzhou 310013, Peoples R China
[2] Zhejiang Prov Key Lab Geriatr, Hangzhou 310013, Peoples R China
[3] First Peoples Hosp Hangzhou, Dept Lab Med, Hangzhou 310006, Peoples R China
基金
美国国家科学基金会;
关键词
SQUAMOUS-CELL CARCINOMA; SINGLE-NUCLEOTIDE POLYMORPHISMS; COLORECTAL-CANCER; GENETIC POLYMORPHISMS; A870G POLYMORPHISM; HEAD; NECK; ASSOCIATION; CCND1; VARIANTS;
D O I
10.1155/2013/689048
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Recently, there have been a number of studies on the association between cyclin D1 G870A polymorphism and nasopharyngeal carcinoma risk. However, the results of previous reports remain controversial and ambiguous. Thus, we performed a meta-analysis to explore more precisely the association between cyclin D1 G870A polymorphism and the risk of nasopharyngeal carcinoma. No significant association was found between cyclin D1 G870A polymorphism and nasopharyngeal carcinoma risk in total population analysis. In the subgroup meta-analysis by ethnicity, a negative association was shown in Caucasian subgroup, and no significant association in any genetic models among Asians was observed. In summary, positive results have been shown on the search for polymorphic variants influencing the risk of NPC. This meta-analysis provides evidence of the association between CCND1 G870A polymorphism and NPC risk, supporting the hypothesis that CCND1 870A allele probably acts as an important NPC protective factor in Caucasians but not in Asians. Since the results of our meta-analysis are preliminary and may be biased by the relatively small number of subjects, they still need to be validated by well-designed studies using larger samples in the future.
引用
收藏
页数:8
相关论文
共 36 条
[1]   Cyclin D1 G870A polymorphism is associated with an increased risk of hepatocellular carcinoma in the Turkish population: Case-control study [J].
Akkiz, Hikmet ;
Bayram, Sueleyman ;
Bekar, Aynur ;
Akgollu, Ersin ;
Ozdil, Burhan .
CANCER EPIDEMIOLOGY, 2010, 34 (03) :298-302
[2]   Validation of Genetic Sequence Variants as Prognostic Factors in Early-Stage Head and Neck Squamous Cell Cancer Survival [J].
Azad, Abul Kalam ;
Bairati, Isabelle ;
Samson, Elodie ;
Cheng, Dangxiao ;
Mirshams, Maryam ;
Qiu, Xin ;
Savas, Sevtap ;
Waldron, John ;
Wang, Changshu ;
Goldstein, David ;
Xu, Wei ;
Meyer, Francois ;
Liu, Geoffrey .
CLINICAL CANCER RESEARCH, 2012, 18 (01) :196-206
[3]  
Canbay E, 2010, ANTICANCER RES, V30, P3093
[4]   Oncogenic virus-associated neoplasia: A role for cyclin D1 genotypes influencing the age of onset of disease? [J].
Catarino, R. ;
Pereira, D. ;
Breda, E. ;
Coelho, A. ;
Matos, A. ;
Lopes, C. ;
Medeiros, R. .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2008, 370 (01) :118-122
[5]   Association of the A870G cyclin D1 gene polymorphism with genetic susceptibility to nasopharyngeal carcinoma [J].
Catarino, Raquel J. ;
Breda, Eduardo ;
Coelho, Vania ;
Pinto, Daniela ;
Sousa, Hugo ;
Lopes, Carlos ;
Medeiros, Rui .
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2006, 28 (07) :603-608
[6]   The enigmatic epidemiology of nasopharyngeal carcinoma [J].
Chang, Ellen T. ;
Adami, Hans-Olov .
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2006, 15 (10) :1765-1777
[7]  
Deng L, 2002, ACTA BIOCH BIOPH SIN, V34, P16
[8]   Proliferation, cell cycle and apoptosis in cancer [J].
Evan, GI ;
Vousden, KH .
NATURE, 2001, 411 (6835) :342-348
[9]   Association of Selected Variants in Genes Involved in Cell Cycle and Apoptosis with Bladder Cancer Risk in North Indian Population [J].
Gangwar, Ruchika ;
Mittal, Rama Devi .
DNA AND CELL BIOLOGY, 2010, 29 (07) :349-356
[10]   P21/WAF1 and cyclin D1 variants and oral squamous cell carcinoma [J].
Gomes, Carolina C. ;
Drummond, Sergio N. ;
Guimaraes, Andre L. S. ;
Andrade, Carlos I. ;
Mesquita, Ricardo A. ;
Gomez, Ricardo S. .
JOURNAL OF ORAL PATHOLOGY & MEDICINE, 2008, 37 (03) :151-156